Search - tctmd.com

Displaying 141 - 160 of 401

Sort: Relevancy | Date

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

Presentation ESC 2024

BedMed and BedMed-Frail randomized controlled trials

Presenter: Scott Garrison

August 31, 2024

Presentation ESC 2024

QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension

Presenter: Stefano Taddei

August 31, 2024

Presentation ESC 2024

Continuation versus Interruption of Oral Anticoagulation during TAVI

Presenter: Dirk-Jan van Ginkel

August 31, 2024

News Conference News ESC 2024

New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day

Yael L. Maxwell

August 31, 2024

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

L.A. McKeown

August 31, 2024

News Conference News ESC 2024

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

Todd Neale

August 30, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Conference News ESC 2024

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

L.A. McKeown

August 30, 2024

News Daily News

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

Yael L. Maxwell

August 29, 2024

News Daily News

Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

Caitlin E. Cox

August 28, 2024

News Daily News

ACC/AHA Clarify How Social Determinants of Health Impact CVD

Caitlin E. Cox

August 28, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Todd Neale

August 23, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

Advertisement

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

BedMed and BedMed-Frail randomized controlled trials

QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension

Continuation versus Interruption of Oral Anticoagulation during TAVI

New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day

Polypills Show Promise in Diverse Hypertensive Patient Groups

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

ACC/AHA Clarify How Social Determinants of Health Impact CVD

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Scientific Statement Reviews Current Antithrombotic Options in PAD

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Platelet Hyperreactivity Score May Improve CVD Risk Detection

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content